These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7893853)

  • 1. Decreased phospholipase A2 activity in Alzheimer brains.
    Gattaz WF; Maras A; Cairns NJ; Levy R; Förstl H
    Biol Psychiatry; 1995 Jan; 37(1):13-7. PubMed ID: 7893853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease.
    Gattaz WF; Cairns NJ; Levy R; Förstl H; Braus DF; Maras A
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(3):129-31. PubMed ID: 8739397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relevance of metabolism of membrane phospholipids for Alzheimer dementia].
    Gattaz WF; Levy R; Cairns NJ; Förstl H; Braus DF; Maras A
    Fortschr Neurol Psychiatr; 1996 Jan; 64(1):8-12. PubMed ID: 8850090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A frontal variant of Alzheimer's disease exhibits decreased calcium-independent phospholipase A2 activity in the prefrontal cortex.
    Talbot K; Young RA; Jolly-Tornetta C; Lee VM; Trojanowski JQ; Wolf BA
    Neurochem Int; 2000 Jul; 37(1):17-31. PubMed ID: 10781842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity.
    Ross BM; Moszczynska A; Erlich J; Kish SJ
    J Neurochem; 1998 Feb; 70(2):786-93. PubMed ID: 9453575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of phospholipase A2 by amyloid beta-peptides in vitro.
    Lehtonen JY; Holopainen JM; Kinnunen PK
    Biochemistry; 1996 Jul; 35(29):9407-14. PubMed ID: 8755719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.
    Schaeffer EL; Forlenza OV; Gattaz WF
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):37-51. PubMed ID: 18853146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet phospholipase A(2) activity in Alzheimer's disease and mild cognitive impairment.
    Gattaz WF; Forlenza OV; Talib LL; Barbosa NR; Bottino CM
    J Neural Transm (Vienna); 2004 May; 111(5):591-601. PubMed ID: 15088152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain.
    Stephenson DT; Lemere CA; Selkoe DJ; Clemens JA
    Neurobiol Dis; 1996 Feb; 3(1):51-63. PubMed ID: 9173912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of the activation of [3H]hemicholinium-3 binding by phospholipase A2.
    Yamada K; Saltarelli MD; Coyle JT
    J Pharmacol Exp Ther; 1989 Jun; 249(3):836-42. PubMed ID: 2732947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible involvement of phospholipase A2 in the pathogenesis of schizophrenia].
    Gattaz WF; Nevalainen TJ; Kinnunen PK
    Fortschr Neurol Psychiatr; 1990 Apr; 58(4):148-53. PubMed ID: 2354835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of association between genetic polymorphisms of phospholipase A2 enzymes and Alzheimer's disease.
    Cordeiro Q; Noguti R; Bottino CM; Vallada H
    Arq Neuropsiquiatr; 2010 Apr; 68(2):189-93. PubMed ID: 20464283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased platelet phospholipase A2 activity in schizophrenia.
    Gattaz WF; Schmitt A; Maras A
    Schizophr Res; 1995 Jul; 16(1):1-6. PubMed ID: 7547640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum phospholipase A2 activity in schizophrenia: a replication study.
    Gattaz WF; Hübner CV; Nevalainen TJ; Thuren T; Kinnunen PK
    Biol Psychiatry; 1990 Sep; 28(6):495-501. PubMed ID: 2223919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease.
    Forlenza OV; Schaeffer EL; Gattaz WF
    J Neural Transm (Vienna); 2007 Feb; 114(2):231-8. PubMed ID: 17131232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Accelerated breakdown of membrane phospholipids in schizophrenia--implications for the hypofrontality hypothesis].
    Gattaz WF; Brunner J; Schmitt A; Maras A
    Fortschr Neurol Psychiatr; 1994 Dec; 62(12):489-96. PubMed ID: 7835820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase A2 (PLA2) activity in gerbil brain: characterization of cytosolic and membrane-associated forms and effects of ischemia and reperfusion on enzymatic activity.
    Bonventre JV; Koroshetz WJ
    J Lipid Mediat; 1993; 6(1-3):457-71. PubMed ID: 8358004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipase A2 activation influences the processing and secretion of the amyloid precursor protein.
    Emmerling MR; Moore CJ; Doyle PD; Carroll RT; Davis RE
    Biochem Biophys Res Commun; 1993 Nov; 197(1):292-7. PubMed ID: 8250938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of phospholipase A2 activity reduces membrane fluidity in rat hippocampus.
    Schaeffer EL; Bassi F; Gattaz WF
    J Neural Transm (Vienna); 2005 May; 112(5):641-7. PubMed ID: 15830123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.
    Sun GY; Xu J; Jensen MD; Simonyi A
    J Lipid Res; 2004 Feb; 45(2):205-13. PubMed ID: 14657205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.